Table 4.
The clustering effects of metabolic factors in metabolic syndrome
No. of metabolic factors | Abnormal metabolic factor | Male | Female | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||||
WC | HP | Glu | TG | HDL-C | Frequency (observed/expected) | O/E | 95% CI | Frequency (observed/expected) | O/E | 95% CI | |
1 | + | − | − | − | − | 3.8/5.9 | 0.65 | 0.51–0.82 | 8.4/12.2 | 0.69 | 0.58–0.82 |
− | + | − | − | − | 9.0/10.1 | 0.89 | 0.77–1.03 | 4.9/7.6 | 0.65 | 0.53–0.79 | |
− | − | + | − | − | 2.0/3.9 | 0.50 | 0.36–0.70 | 0.8/3.0 | 0.28 | 0.18–0.42 | |
− | − | − | + | − | 8.2/13.0 | 0.63 | 0.52–0.77 | 2.1/6.7 | 0.31 | 0.24–0.40 | |
− | − | − | − | + | 2.7/4.0 | 0.68 | 0.48–0.95 | 8.0/9.7 | 0.82 | 0.71–0.94 | |
| |||||||||||
2 | + | + | − | − | − | 2.3/3.7 | 0.64 | 0.47–0.87 | 3.6/4.4 | 0.81 | 0.64–1.01 |
+ | − | + | − | − | 0.6/1.4 | 0.40 | 0.21–0.75 | 0.9/1.7 | 0.50 | 0.33–0.78 | |
+ | − | − | + | − | 3.6/4.7 | 0.76 | 0.56–1.01 | 1.9/3.9 | 0.50 | 0.35–0.69 | |
+ | − | − | − | + | 0.6/1.5 | 0.41 | 0.23–0.75 | 4.6/5.7 | 0.81 | 0.66–1.00 | |
− | + | + | − | − | 1.7/2.4 | 0.69 | 0.51–0.94 | 0.7/1.1 | 0.64 | 0.40–1.04 | |
− | + | − | + | − | 6.0/8.1 | 0.74 | 0.62–0.89 | 1.6/2.5 | 0.66 | 0.47–0.93 | |
− | + | − | − | + | 0.9/2.5 | 0.35 | 0.20–0.61 | 1.4/3.6 | 0.38 | 0.26–0.56 | |
− | − | + | + | − | 2.1/3.1 | 0.68 | 0.49–0.94 | 0.2/1.0 | 0.17 | 0.05–0.59 | |
− | − | + | − | + | 0.4/1.0 | 0.37 | 0.18–0.79 | 0.4/1.4 | 0.31 | 0.17–0.56 | |
− | − | − | + | + | 4.0/3.2 | 1.24 | 0.97–1.60 | 2.6/3.1 | 0.83 | 0.63–1.10 | |
| |||||||||||
3 | + | + | + | − | − | 1.2/0.9 | 1.34 | 0.84–2.15 | 0.9/0.6 | 1.40 | 0.90–2.17 |
+ | + | − | + | − | 4.4/2.9 | 1.49 | 1.17–1.88 | 2.4/1.4 | 1.66 | 1.29–2.14 | |
+ | + | − | − | + | 0.5/0.9 | 0.57 | 0.30–1.09 | 1.7/2.1 | 0.81 | 0.62–1.06 | |
+ | − | + | + | − | 1.2/1.1 | 1.04 | 0.69–1.56 | 0.6/0.6 | 1.01 | 0.58–1.78 | |
+ | − | + | − | + | 0.4/0.3 | 1.10 | 0.46–2.62 | 0.7/0.8 | 0.85 | 0.49–1.49 | |
+ | − | − | + | + | 1.6/1.2 | 1.40 | 1.00–1.94 | 3.2/1.8 | 1.73 | 1.37–2.19 | |
− | + | + | + | − | 3.2/1.9 | 1.62 | 1.22–2.16 | 0.5/0.4 | 1.33 | 0.79–2.23 | |
− | + | + | − | + | 0.3/0.6 | 0.42 | 0.21–0.83 | 0.5/0.5 | 0.93 | 0.47–1.84 | |
− | + | − | + | + | 2.0/2.0 | 1.01 | 0.71–1.43 | 1.1/1.1 | 0.99 | 0.71–1.37 | |
− | − | + | + | + | 1.1/0.8 | 1.41 | 0.90–2.21 | 0.3/0.4 | 0.72 | 0.37–1.39 | |
| |||||||||||
4 | + | + | + | + | − | 2.1/0.7 | 3.01 | 2.21–4.09 | 1.3/0.2 | 6.28 | 4.76–8.27 |
+ | + | + | − | + | 0.4/0.2 | 1.86 | 0.88–3.91 | 0.8/0.3 | 2.68 | 1.88–3.82 | |
+ | + | − | + | + | 2.1/0.7 | 2.86 | 2.04–3.99 | 2.6/0.7 | 3.85 | 3.03–4.90 | |
+ | − | + | + | + | 0.6/0.3 | 2.12 | 1.22–3.67 | 1.1/0.3 | 4.37 | 3.04–6.27 | |
− | + | + | + | + | 1.0/0.5 | 2.11 | 1.35–3.30 | 0.7/0.2 | 4.19 | 2.49–7.06 | |
| |||||||||||
5 | + | + | + | + | + | 1.3/0.2 | 7.36 | 5.27–10.25 | 2.2/0.1 | 22.83 | 17.69–29.42 |
WC, waist circumference; HP, hypertension; Glu, hyperglycemia; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; O/E, ratio of observed prevalence to expected prevalence; CI, confidence interval.